Are you Dr. Walker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
395 Commercial CT
Ste E
Venice, FL 34292Phone+1 941-486-1404Fax+1 941-486-4146
Summary
- Dr. Monica Walker, MD is a board certified dermatologist in Venice, Florida. She is currently licensed to practice medicine in Florida, New Jersey, and California.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Dermatology, 1991 - 1993
- University at BuffaloResidency, Dermatology, 1989 - 1991
- University of Florida College of Medicine JacksonvilleResidency, Internal Medicine, 1986 - 1989
- Marshall University Joan C. Edwards School of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 1992 - Present
- NJ State Medical License 1993 - Present
- FL State Medical License 1987 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 57 citationsAntibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses i...Daniel M. Musher, Susan B. Manoff, Richard D. McFetridge, Charles Liss, Rocio D. Marchese
Human Vaccines. 2011-09-01 - 170 citationsDurable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results...Jürgen K. Rockstroh, Edwin DeJesus, Jeffrey L. Lennox, Yazdan Yazdanpanah, Michael S. Saag
Journal of Acquired Immune Deficiency Syndromes. 2013-05-01 - 26 citationsEfficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses ...Edwin DeJesus, Jürgen K. Rockstroh, Jeffrey L. Lennox, Michael S. Saag, Adriano Lazzarin
HIV Clinical Trials. 2012-07-01
Professional Memberships
- Fellow